RxDoctor Payments Data

Russell Carlisle

Family Medicine · Wesson, MSNPI 1689263717

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,568,602 of the $1,568,606 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Boehringer Ingelheim. Reporting peaked in 2024 at $642,010 and has fallen 89.9% since, to $64,575 in 2025. Among family medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,568,606in general payments, 2019–2025

Across 24 payments — averaging $65,359 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$1.6M

What the payments were for

  • Consulting fees$1,568,602100%
  • Food & beverage$40%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim24$1,568,606

How this compares

$1,568,606 in reported general payments places this provider in the 95th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi →

Other family medicine in Wesson

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →